Moonlake Immunotherapeutics Stock Buy Hold or Sell Recommendation
| MLTX Stock | USD 38.55 0.73 1.93% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding MoonLake Immunotherapeutics is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell MoonLake Immunotherapeutics given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for MoonLake Immunotherapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out MoonLake Immunotherapeuti Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as MoonLake and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards MoonLake Immunotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
MoonLake |
Execute MoonLake Immunotherapeuti Buy or Sell Advice
The MoonLake recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on MoonLake Immunotherapeutics. Macroaxis does not own or have any residual interests in MoonLake Immunotherapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute MoonLake Immunotherapeuti's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | About Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
MoonLake Immunotherapeuti Trading Alerts and Improvement Suggestions
| MoonLake Immunotherapeuti generated a negative expected return over the last 90 days | |
| MoonLake Immunotherapeuti has high historical volatility and very poor performance | |
| MoonLake Immunotherapeuti has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (121.24 B) with profit before overhead, payroll, taxes, and interest of 0. | |
| MoonLake Immunotherapeutics currently holds about 92.71 M in cash with (116.59 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.51. | |
| MoonLake Immunotherapeuti has a frail financial position based on the latest SEC disclosures | |
| Over 85.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 3027483 shares by Santos Da Silva Jorge of MoonLake Immunotherapeuti subject to Rule 16b-3 |
MoonLake Immunotherapeuti Returns Distribution Density
The distribution of MoonLake Immunotherapeuti's historical returns is an attempt to chart the uncertainty of MoonLake Immunotherapeuti's future price movements. The chart of the probability distribution of MoonLake Immunotherapeuti daily returns describes the distribution of returns around its average expected value. We use MoonLake Immunotherapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of MoonLake Immunotherapeuti returns is essential to provide solid investment advice for MoonLake Immunotherapeuti.
| Mean Return | -0.47 | Value At Risk | -5.09 | Potential Upside | 4.59 | Standard Deviation | 3.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of MoonLake Immunotherapeuti historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
MoonLake Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument, such as MoonLake Immunotherapeuti, soars without any apparent reason? This usually happens because many institutional investors are aggressively trading MoonLake Immunotherapeutics back and forth among themselves.
| Shares | Marshall Wace Asset Management Ltd | 2024-12-31 | 1.2 M | Polar Capital Holdings Plc | 2024-12-31 | 1.1 M | Alliancebernstein L.p. | 2024-12-31 | 1 M | Fred Alger Management, Llc | 2024-12-31 | 673.8 K | Hood River Capital Management Llc | 2024-12-31 | 649.6 K | Nuveen Asset Management, Llc | 2024-12-31 | 595.6 K | Ing Investment Management Llc | 2024-12-31 | 448.9 K | Finepoint Capital Lp | 2024-12-31 | 447.9 K | Camber Capital Management Llc | 2024-12-31 | 441 K | Bvf Inc | 2024-12-31 | 19.8 M | Cormorant Asset Management, Llc | 2024-12-31 | 8.5 M |
MoonLake Immunotherapeuti Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to MoonLake Immunotherapeuti or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that MoonLake Immunotherapeuti's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a MoonLake stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.46 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 3.08 | |
Ir | Information ratio | -0.12 |
MoonLake Immunotherapeuti Volatility Alert
MoonLake Immunotherapeutics exhibits very low volatility with skewness of 0.1 and kurtosis of -0.52. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure MoonLake Immunotherapeuti's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact MoonLake Immunotherapeuti's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.MoonLake Immunotherapeuti Fundamentals Vs Peers
Comparing MoonLake Immunotherapeuti's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MoonLake Immunotherapeuti's direct or indirect competition across all of the common fundamentals between MoonLake Immunotherapeuti and the related equities. This way, we can detect undervalued stocks with similar characteristics as MoonLake Immunotherapeuti or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MoonLake Immunotherapeuti's fundamental indicators could also be used in its relative valuation, which is a method of valuing MoonLake Immunotherapeuti by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MoonLake Immunotherapeuti to competition |
| Fundamentals | MoonLake Immunotherapeuti | Peer Average |
| Return On Equity | -0.25 | -0.31 |
| Return On Asset | -0.18 | -0.14 |
| Current Valuation | 1.95 B | 16.62 B |
| Shares Outstanding | 63.28 M | 571.82 M |
| Shares Owned By Insiders | 15.47 % | 10.09 % |
| Shares Owned By Institutions | 84.53 % | 39.21 % |
| Number Of Shares Shorted | 8.05 M | 4.71 M |
| Price To Book | 5.36 X | 9.51 X |
| EBITDA | (141.71 M) | 3.9 B |
| Net Income | (121.24 B) | 570.98 M |
| Cash And Equivalents | 92.71 M | 2.7 B |
| Cash Per Share | 2.51 X | 5.01 X |
| Total Debt | 2.83 M | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 25.51 X | 2.16 X |
| Book Value Per Share | 7.08 X | 1.93 K |
| Cash Flow From Operations | (116.59 B) | 971.22 M |
| Short Ratio | 21.56 X | 4.00 X |
| Earnings Per Share | (1.89) X | 3.12 X |
| Target Price | 78.67 | |
| Number Of Employees | 100 | 18.84 K |
| Beta | 1.3 | -0.15 |
| Market Capitalization | 2.44 B | 19.03 B |
| Total Asset | 477.93 B | 29.47 B |
| Retained Earnings | (235.59 B) | 9.33 B |
| Working Capital | 451.82 M | 1.48 B |
| Net Asset | 477.93 B |
Note: Disposition of 3027483 shares by Santos Da Silva Jorge of MoonLake Immunotherapeuti subject to Rule 16b-3 [view details]
MoonLake Immunotherapeuti Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as MoonLake . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About MoonLake Immunotherapeuti Buy or Sell Advice
When is the right time to buy or sell MoonLake Immunotherapeutics? Buying financial instruments such as MoonLake Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having MoonLake Immunotherapeuti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Broad Market ETFs Thematic Idea Now
Broad Market ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Broad Market ETFs theme has 72 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Broad Market ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.